Fresenius Group Overview

Results Centre

Q2/2017 Results

Fresenius confirms its guidance after a strong second quarter with double-digit sales and earnings growth

  • Sustainable strong momentum also in the second quarter
  • Continued strong increases in sales and earnings
  • Pleasant business development of Quirónsalud
  • A focus in H2/17 will be to close the acquisitions announced by Fresenius Kabi

Selected Key Figures Q2/2017

1 Constant currency